Muramidase and lactoferrin in adenoidal hypertrophies, hypertrophic and chronic infected tonsil tissue - A quantitative analysis;Lysozym und laktoferrin in adenoiden, hyperplastischen und chronisch entzündeten tonsillen - Eine quantitative analyses

Laryngo- Rhino- Otologie

Volumn 84, Issue 9, 2005, Pages 660-664

  Schwaab, Matthias ^a,c   Euteneuer, S ^a   Lautermann, J ^a,b   Sudhoff, H ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c St Elisabeth Hospital Bochum   (Germany)

Author keywords

Adenoids; Biofilm; Defense system; ELISA; Lactoferrin; Muramidase; Tonsils

Indexed keywords

LACTOFERRIN; LYSOZYME;

ADENOID; ARTICLE; BIOFILM; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; HYPERTROPHY; INFECTION; PALATINE TONSIL; PRIORITY JOURNAL; PROTEIN CONTENT; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; TONSIL DISEASE; TONSILLITIS;

ADENOIDS; ADOLESCENT; ADULT; AGE FACTORS; BIOFILMS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DATA INTERPRETATION, STATISTICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYPERTROPHY; LACTOFERRIN; MIDDLE AGED; MURAMIDASE; TONSIL; TONSILLECTOMY; TONSILLITIS;

EID: 26044471886     PISSN: 09358943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-870297     Document Type: Article

References (30)

1. Flemming A. On a remarkable bacteriolytic element found in tissues and secretions. Proc R Soc Lond B Biol Sci 1922; 93: 306-317
2. Schröder J-M. Epithelial antimicrobial peptides: Innate local host response elements. CMLS, Cell Mol Life Sci 1999; 56: 32-46
3. Stenfors LE, Bye HM, Raisanen S. Immunocytochemical localization of lysozyme and lactoferrin attached to surface bacteria of the palatine tonsils during infectious mononucleosis. J Laryngol Otol 2002; 116: 264-268
4. Thompson AB, Bohling T, Payvandi F, Rennard SI. Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. J Lab Clin Med 1990; 115: 148-158
5. Dick W. Lysozyme: basic facts and diagnostic importance. Fortschr Med 1982; 100: 1230-1234
6. Sava G, Benetti A, Ceschia V, Pacor S. Lysozyme and cancer: role of exogenous lysozyme as anticancer agent (review). Anticancer Res 1989; 9: 583-591
7. Meyer P, Zechel T. Quantitative Untersuchungen an den Enzymen Lysozym und Phosphohexoseisomerase im Mischspeichel beim oralen Plattenepithelkarzinom. HNO 2001; 49: 626-629
8. Harbitz O, Jenssen AO, Smidsrod O. Lysozyme and lactoferrin in sputum from patients with chronic obstructive lung disease. Eur J Respir Dis 1984; 65: 512-520
9. Ellison RT III, Giehl TJ, LaForce FM. Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect Immun 1988; 56: 2774-2781
10. Otto BR, Verweij-van Vught AM, MacLaren DM. Transferrins and heme-compounds as iron sources for pathogenic bacteria. Crit Rev Microbiol 1992; 18: 217-233
11. Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K, Tomita M. Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta 1992; 1121: 130-136
12. Ellison RT III, Giehl TJ. Killing of gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest 1991; 88: 1080-1091
13. Singh PK, Tack BF, McCray PB, Welsch MJ. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol 2000; 279: 799-805
14. Marcotte H, Lavoie MC. Oral microbial ecology and the role of salivary immunoglobulin A. Microbiol Mol Biol Rev 1998; 62: 71-109
15. Brandtzaeg P. Immunology of tonsils and adenoids: everything the ENT surgeon needs to know. Int J Pediatr Otorhinolaryngol 2003; 67 Suppl 1: 69-76
16. Aliani S, Graf N. Pädiatrische immunologische Aspekte der Tonsillektomie. HNO 2002; 50: 410-414
17. Stenfors LE, Bye HM, Raisanen S. Bacterial coatimg with immunoglobulins on the palatine tonsils during infectious mononucleosis: immuncytochemical study with gold markers. J Laryngol Otol 2001; 115: 101-105
18. Stenfors LE, Bye HM, Raisanen S, Myklebust R. Bacterial penetration into tonsillar surface epithelium during infectious mononucleosis. J Laryngol Otol 200; 114: 848-852
19. Chae SW, Lee SH, Cho JH, Lee HM, Choi G, Hwang SJ. Expression of human beta-defensin 1 mRNA in human palatine tonsil. Acta Otolaryngol 2001; 121: 414-418
20. Weise JB, Meyer JE, Helmer H, Wittrock H, Maune S. A newly discovered function of palatine tonsils in immune defence: the expression of defensins. Otolaryngol Pol 2002; 56: 409-413
21. Costongs GM, Hemrika MH, Engels LG, Bos LP, Bas BM, Flendrig JA, Janson PC. Faecal lysozyme: determination, reference intervals and some data in gastro-intestinal disease. Clin Chim Acta 1987; 167: 125-134
22. Ward M, Ferguson A, Eastwood MA. Jejunal lysozyme activity and the Paneth cell in celiac disease. Gut 1979; 20: 55-58
23. Akinbi HT, Equad R, Bhatt H, Weaver TE. Bacterial killing is enhanced by expression of lysozyme in the lungs of transgenic mice. J Immun 2000; 165: 5760-5766
24. Travis SM, Conway BA, Zabner J, Smith JJ, Anderson NN, Singh PK, Greenberg EP, Welsch MJ. Acitivity of abundant antimicribials of the human airway. Am J Respir Cell Mol Biol 1999; 20: 872-879
25. Van Staaji BK, Van den Akker EH, Rovers MM, Hordijk GJ, Hoes AW, Schilder AGM. Effectiveness of adenotonsillectomy in children with mild symptoms of throat infections or adenotonsillar hypertrophy: open, randomised controlled trial. BMJ, doi: 10.116/gmj.8210.827917.7c, (published 10 September 2004)
26. Chole RA, Faddis BT. Anatomical evidence of microbial films in tonsillar tissues: a possible mechanism to explain chronicity. Arch Otolaryngol Head Neck Surg 2003; 129: 634-636
27. Meluleni GJ, Grout M, Evans DJ, Pier GB. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients. J Immunol 1995; 155: 2029-2038
28. Singh PK, Parsek MR, Greenberg EP, Welsh MJ. A component of innate immunity prevents bacterial biofilm development. Nature 2002; 417: 551-555
29. Rogan MP, Taggart CC, Greene CM, Murphy PG, O'Neill SJ, McElvaney NG. Loss of microbicidal Activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. J Infect Diseas 2004; 190: 1245-125
30. Brogan TD, Ryley HC, Neale L, Yassa J. Soluble proteins of bronchopulmonary secretions from patients with cystic fibrosis, asthma, and bronchitis. Thorax 1975; 30: 72-79